172 related articles for article (PubMed ID: 15192149)
1. CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes.
McGregor CM; Schoenberger SP; Green EA
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9345-50. PubMed ID: 15192149
[TBL] [Abstract][Full Text] [Related]
2. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions.
Gorbachev AV; Heeger PS; Fairchild RL
J Immunol; 2001 Feb; 166(4):2323-32. PubMed ID: 11160289
[TBL] [Abstract][Full Text] [Related]
3. CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.
Vaitaitis GM; Waid DM; Yussman MG; Wagner DH
Immunology; 2017 Oct; 152(2):243-254. PubMed ID: 28542921
[TBL] [Abstract][Full Text] [Related]
4. CD154-dependent priming of diabetogenic CD4(+) T cells dissociated from activation of antigen-presenting cells.
Amrani A; Serra P; Yamanouchi J; Han B; Thiessen S; Verdaguer J; Santamaria P
Immunity; 2002 May; 16(5):719-32. PubMed ID: 12049723
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T helper cells use CD154-CD40 interactions to counteract T reg cell-mediated suppression of CD8+ T cell responses to influenza.
Ballesteros-Tato A; León B; Lund FE; Randall TD
J Exp Med; 2013 Jul; 210(8):1591-601. PubMed ID: 23835849
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
Green KA; Noelle RJ; Durell BG; Green WR
J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
van Maurik Av; Herber M; Wood KJ; Jones ND
J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
[TBL] [Abstract][Full Text] [Related]
8. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
Front Immunol; 2019; 10():306. PubMed ID: 30863408
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets.
Van Belle TL; Nierkens S; Arens R; von Herrath MG
Immunity; 2012 Jun; 36(6):1060-72. PubMed ID: 22579473
[TBL] [Abstract][Full Text] [Related]
10. CD154+ CD4+ T-cell dependence for effective memory influenza virus-specific CD8+ T-cell responses.
Olson MR; Seah SG; Edenborough K; Doherty PC; Lew AM; Turner SJ
Immunol Cell Biol; 2014 Aug; 92(7):605-11. PubMed ID: 24777309
[TBL] [Abstract][Full Text] [Related]
11. Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells.
Green EA; Wong FS; Eshima K; Mora C; Flavell RA
J Exp Med; 2000 Jan; 191(2):225-38. PubMed ID: 10637268
[TBL] [Abstract][Full Text] [Related]
12. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre ML; Thistlethwaite JR; Pearson TC; Larsen CP; Newell KA
Transplantation; 2001 May; 71(9):1351-4. PubMed ID: 11403253
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes.
Green EA; Gorelik L; McGregor CM; Tran EH; Flavell RA
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10878-83. PubMed ID: 12949259
[TBL] [Abstract][Full Text] [Related]
14. CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination.
Raisky O; Spriewald BM; Morrison KJ; Ensminger S; Mohieddine T; Obadia JF; Yacoub MH; Rose ML
J Heart Lung Transplant; 2003 Feb; 22(2):177-83. PubMed ID: 12581766
[TBL] [Abstract][Full Text] [Related]
15. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
[TBL] [Abstract][Full Text] [Related]
16. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
17. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition.
Gorbachev AV; DiIulio NA; Fairchild RL
J Immunol; 2001 Jul; 167(1):156-62. PubMed ID: 11418644
[TBL] [Abstract][Full Text] [Related]
18. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
19. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
20. Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.
Edelmann KH; Wilson CB
J Virol; 2001 Jan; 75(2):612-21. PubMed ID: 11134274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
